8-K - Allogene Therapeutics, Inc. - 8.01

Form 8-K - Current report: SEC Accession No. 0001193125-26-152866

Filing Date: 2026-04-13

Accepted: 2026-04-13 16:09:04

Documents: 11

Period of Report: 2026-04-13

Items: Item 8.01: Other Events

Allogene Therapeutics, Inc. (Filer) CIK : 0001737287 (see all company filings) EIN. : 823562771 | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-38693 | Film No.: 26857900 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)

1 | 8-K | d249901d8k.htm iXBRL | 8-K

2 | XBRL TAXONOMY EXTENSION SCHEMA | allo-20260413.xsd | EX-101.SCH

3 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | allo-20260413_lab.xml | EX-101.LAB

4 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | allo-20260413_pre.xml | EX-101.PRE